VYNE Therapeutics Inc.
VYNE
$1.43
-$0.45-23.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.35% | -10.14% | -9.13% | -7.83% | 503.66% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.57% | -41.32% | 33.42% | 58.85% | 50.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 2.17% | -14.81% | 0.00% | 0.00% |
| Total Current Assets | -12.37% | -12.22% | -7.15% | -5.98% | 448.02% |
|
|
|||||
| Total Current Assets | -12.37% | -12.22% | -7.15% | -5.98% | 448.02% |
| Net Property, Plant & Equipment | 68.85% | -19.21% | -16.11% | -13.04% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.98% | -6.62% | 113.75% | -15.97% | -13.72% |
| Total Assets | -12.20% | -12.06% | -5.48% | -6.15% | 407.01% |
|
|
|||||
| Total Accounts Payable | -32.09% | -11.74% | 61.57% | 68.47% | 131.70% |
| Total Accrued Expenses | 18.70% | 95.38% | 128.99% | -53.96% | -38.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.51% | 2.50% | 2.56% | 1.74% | -- |
| Total Finance Division Other Current Liabilities | 160.47% | -61.53% | 42.21% | 6.67% | -- |
| Total Other Current Liabilities | 160.47% | -61.53% | 42.21% | 6.67% | -- |
| Total Current Liabilities | 17.04% | 7.72% | 69.61% | -8.07% | 16.89% |
|
|
|||||
| Total Current Liabilities | 17.04% | 7.72% | 69.61% | -8.07% | 16.89% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -60.32% | -36.36% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 0.00% | 0.00% |
| Total Liabilities | 17.04% | 7.49% | 41.81% | -7.20% | 15.31% |
|
|
|||||
| Common Stock & APIC | 0.07% | 0.09% | 0.11% | 0.13% | 11.97% |
| Retained Earnings | -1.67% | -1.72% | -1.35% | -0.90% | -0.90% |
| Treasury Stock & Other | -41.18% | 158.62% | 17.14% | -369.23% | -- |
| Total Common Equity | -18.02% | -15.14% | -10.20% | -6.05% | 671.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.02% | -15.14% | -10.20% | -6.05% | 671.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.02% | -15.14% | -10.20% | -6.05% | 671.27% |
|
|
|||||